期刊
PHARMACOLOGY & THERAPEUTICS
卷 221, 期 -, 页码 -出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pharmthera.2020.107744
关键词
Long noncoding RNA; Diagnosis and prognosis; Cardiocerebrovascular disease
资金
- National Natural Science Foundation of China [81770381, 31601089]
- Zhishan Youth Scholar Program of SEU
Long noncoding RNAs (lncRNAs) play crucial roles in cardiocerebrovascular diseases by regulating gene expression and influencing disease progression. Studies have shown that abnormal expression of lncRNAs is closely related to the occurrence and progression of these diseases, making them potential biomarkers for diagnosis and prognosis.
Cardiocerebrovascular disease is a collective term for cardiovascular and cerebrovascular diseases. Because of the complex mechanisms involved in cardiocerebrovascular diseases, limited effective treatments have been developed. With advancements in precision medicine, studies have focused on long noncoding RNAs (lncRNAs) in cerebrovascular diseases. LncRNAs, which are over 200 nucleotides long, regulate gene expression at epigenetic, transcriptional, and post-transcriptional levels. Moreover, lncRNAs play pivotal roles in the progression of cardiocerebrovascular diseases. For example, recent studies suggested that abnormal expression of lncRNAs are closely related to the occurrence and progression of these diseases. LncRNAs regulate gene expression by specifically binding to mRNA to modulate disease progression, serving as biomarkers for the diagnosis and prognosis of cardiocerebrovascular diseases. In this review, we discuss the roles, mechanisms, and clinical value of lncRNAs in cardiocerebrovascular diseases, providing a new perspective for the diagnosis and treatment of the diseases. (c) 2020 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据